Invited Review: DNA methylation-based classification of paediatric brain tumours
- PMID: 31955441
- DOI: 10.1111/nan.12598
Invited Review: DNA methylation-based classification of paediatric brain tumours
Abstract
DNA methylation-based machine learning algorithms represent powerful diagnostic tools that are currently emerging for several fields of tumour classification. For various reasons, paediatric brain tumours have been the main driving forces behind this rapid development and brain tumour classification tools are likely further advanced than in any other field of cancer diagnostics. In this review, we will discuss the main characteristics that were important for this rapid advance, namely the high clinical need for improvement of paediatric brain tumour diagnostics, the robustness of methylated DNA and the consequential possibility to generate high-quality molecular data from archival formalin-fixed paraffin-embedded pathology specimens, the implementation of a single array platform by most laboratories allowing data exchange and data pooling to an unprecedented extent, as well as the high suitability of the data format for machine learning. We will further discuss the four most central output qualities of DNA methylation profiling in a diagnostic setting (tumour classification, tumour sub-classification, copy number analysis and guidance for additional molecular testing) individually for the most frequent types of paediatric brain tumours. Lastly, we will discuss DNA methylation profiling as a tool for the detection of new paediatric brain tumour classes and will give an overview of the rapidly growing family of new tumours identified with the aid of this technique.
Keywords: epigenetics; methylation; molecular pathology; neuropathology; paediatric brain tumour; tumour classification.
© 2020 The Authors. Neuropathology and Applied Neurobiology published by John Wiley & Sons Ltd on behalf of British Neuropathological Society.
References
-
- Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 2016; 131: 803-20
-
- Louis DN, Wiestler OD. Cavenee WK WHO Classification of Tumours of the Central Nervous System, Revised 4th edn. Lyon: IARC Press, 2016
-
- Sturm D, Witt H, Hovestadt V, Khuong-Quang DA, Jones DTW, Konermann C et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 2012; 22: 425-37
-
- Pajtler KW, Witt H, Sill M, Jones DTW, Hovestadt V, Kratochwil F et al. Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 2015; 27: 728-43
-
- Korshunov A, Ryzhova M, Hovestadt V, Bender S, Sturm D, Capper D et al. Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers. Acta Neuropathol 2015; 129: 669-78
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical